Artificial Intelligence’s Transformative Role in Illuminating Brain Function in Long COVID Patients Using PET/FDG.

Artificial Intelligence’s Transformative Role in Illuminating Brain Function in Long COVID Patients Using PET/FDG.

Publication date: Jan 10, 2024

Cutting-edge brain imaging techniques, particularly positron emission tomography with Fluorodeoxyglucose (PET/FDG), are being used in conjunction with Artificial Intelligence (AI) to shed light on the neurological symptoms associated with Long COVID. AI, particularly deep learning algorithms such as convolutional neural networks (CNN) and generative adversarial networks (GAN), plays a transformative role in analyzing PET scans, identifying subtle metabolic changes, and offering a more comprehensive understanding of Long COVID’s impact on the brain. It aids in early detection of abnormal brain metabolism patterns, enabling personalized treatment plans. Moreover, AI assists in predicting the progression of neurological symptoms, refining patient care, and accelerating Long COVID research. It can uncover new insights, identify biomarkers, and streamline drug discovery. Additionally, the application of AI extends to non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS), which have shown promise in alleviating Long COVID symptoms. AI can optimize treatment protocols by analyzing neuroimaging data, predicting individual responses, and automating adjustments in real time. While the potential benefits are vast, ethical considerations and data privacy must be rigorously addressed. The synergy of AI and PET scans in Long COVID research offers hope in understanding and mitigating the complexities of this condition.

Open Access PDF

Concepts Keywords
Algorithms AI
Biomarkers cognition
Cnn Long COVID
Fluorodeoxyglucose neuroimaging
Tomography non-invasive brain stimulation


Type Source Name
disease MESH Long COVID
disease MESH aids
pathway REACTOME Metabolism
disease VO time
disease VO USA
disease MESH COVID 19 pandemic
disease MESH sequelae
disease MESH infection
disease IDO history
disease VO effective
drug DRUGBANK Coenzyme M
disease MESH post traumatic stress disorder
disease MESH neuroinflammation
disease VO injection
drug DRUGBANK Dextrose unspecified form
disease VO dose
disease VO age
disease VO protocol
disease MESH inflammation
disease MESH atrophy
disease IDO process
disease MESH rare diseases
disease MESH cognitive dysfunction
disease MESH abnormalities
disease IDO object
disease VO efficiency
disease IDO blood
disease VO organ
disease VO Gap
disease VO population
disease VO effectiveness
disease VO LACK
disease MESH uncertainty
drug DRUGBANK Trestolone
disease MESH neurodegenerative disorders
disease MESH dementia
drug DRUGBANK Medical air
disease MESH neurological disorders
disease MESH Syndrome
disease IDO symptom

Original Article

(Visited 1 times, 1 visits today)